Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,601 to 1,620 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microenvironmental modulation of the developing tumour: an immune-stromal dialogue. | Mol Oncol | 2021 | 32741067 | PubTator, text mining | PubMed |
| Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis. | Clin Exp Rheumatol | 2021 | 32573415 | PubTator, text mining | PubMed |
| Decoding cancer's camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade. | Cancer Drug Resist | 2020 | 35582229 | PubTator, text mining | PubMed |
| Overview of research on fusion genes in prostate cancer. | Transl Cancer Res | 2020 | 35117547 | PubTator, text mining | PubMed |
| A dual MET/AXL small-molecule inhibitor exerts efficacy against gastric carcinoma through killing cancer cells as well as modulating tumor microenvironment. | MedComm (2020) | 2020 | 34766112 | PubTator, text mining | PubMed |
| Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response. | Front Oncol | 2020 | 33747899 | PubTator, text mining | PubMed |
| The current paradigm and challenges ahead for the dormancy of disseminated tumor cells. | Nat Cancer | 2020 | 33681821 | PubTator, text mining | PubMed |
| In-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapy. | Front Immunol | 2020 | 33613517 | PubTator, text mining | PubMed |
| [Role of growth arrest-specific protein 6 in migration and osteogenic differentiation of human periodontal ligament cells]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2020 | 33550330 | PubTator, text mining | PubMed |
| Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications. | Front Genet | 2020 | 33510766 | PubTator, text mining | PubMed |
| A Potent and Selective Dual Inhibitor of AXL and MERTK Possesses Both Immunomodulatory and Tumor-Targeted Activity. | Front Oncol | 2020 | 33425754 | PubTator, text mining | PubMed |
| Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair. | Cells | 2020 | 33396359 | PubTator, text mining | PubMed |
| Corrigendum to "Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor" [Biochem. Biophys. Rep. 21 (2020) 100726]. | Biochem Biophys Rep | 2020 | 33381660 | PubTator, text mining | PubMed |
| Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment. | Front Oncol | 2020 | 33381449 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid of Preeclamptic and Normotensive Pregnant Women Compared to Nonpregnant Women Analyzed with Mass Spectrometry. | ACS Omega | 2020 | 33376863 | PubTator, text mining | PubMed |
| De Novo Partial 13q22-q34 Trisomy with Typical Neurological and Immunological Findings: A Case Report with New Genetic Insights. | Brain Sci | 2020 | 33375380 | PubTator, text mining | PubMed |
| MicroRNA 34a-AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells. | Genes (Basel) | 2020 | 33374832 | PubTator, text mining | PubMed |
| Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses. | Viruses | 2020 | 33374822 | PubTator, text mining | PubMed |
| Why Venous Leg Ulcers Have Difficulty Healing: Overview on Pathophysiology, Clinical Consequences, and Treatment. | J Clin Med | 2020 | 33374372 | PubTator, text mining | PubMed |
| LongGF: computational algorithm and software tool for fast and accurate detection of gene fusions by long-read transcriptome sequencing. | BMC Genomics | 2020 | 33372596 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=81